NextCure Inc.
NXTC | NASDAQ
$6.16
-$0.15 (-2.38%)
Nov 2, 2026, 10:15 AM ET · Market open
Market Data
Market Cap $28.2M
Enterprise Value $13.08M
Beta 1.35
Average Volume 2.13M
Shares Outstanding (Diluted) 5.31M
Shares Change YoY 123.59%
Institutional Ownership 32.68%
Exchange NASDAQ
ISIN US65343E2072
Price Performance
Price Change 1M 21.0%
Price Change 3M 40.0%
Price Change 6M -30.9%
Price Change YTD -56.6%
Price Change 1Y -48.6%
Price Change 3Y -56.5%
Price Change 5Y -94.1%
1M CAGR (ann.) 3.1%
1Y CAGR (ann.) -47.3%
5Y CAGR (ann.) -42.4%
All-Time CAGR -38.5%
Valuation
PE Ratio -0.60
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.01
PS Ratio N/A
Forward PS 4.10
PB Ratio 2.38
P/FCF Ratio -0.78
P/Adj. FCF Ratio -0.75
P/OCF Ratio -0.91
EV/Sales N/A
EV/EBIT -0.31
EV/EBITDA -0.31
EV/FCF -0.35
Earnings Yield -167.7%
FCF Yield -128.1%
Adj. FCF Yield -133.9%
Financial Health
Net Cash $19.4M
Total Debt $4.29M
Cash & Short-Term Investments $20.09M
Total Assets $22.62M
Current Ratio 3.47
Quick Ratio 3.47
Debt / Equity Ratio 0.35
Debt / EBITDA -0.10
Debt / FCF -0.12
OCF / Debt -8.63
Interest Coverage 0.00
Altman Z-Score -32.25
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -4.5%
Returns
Return on Assets -189.0%
Return on Equity -175.5%
Return on Invested Capital -259.9%
Return on Capital Employed -270.9%
Return on Tangible Assets -189.0%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 37.6%
EPS CAGR 5Y 18.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y 10.3%
FCF CAGR 5Y 8.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y 31.0%
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.90
EPS Growth Est (next Q) -72.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $20.00
Price Target Upside 217.0%
Cash Flow
Operating Cash Flow $-36.98M
Free Cash Flow $-36.98M
Adj. Free Cash Flow $-38.67M
FCF Per Share -$6.97
OCF Per Share -$6.97
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-283K
Operating Income $-43.9M
EBITDA $-41.57M
Net Income $-42.75M
EPS (Diluted) -$10.58
Revenue / Employee N/A
Profit / Employee $-1.07M
Employees 40
Add to Watchlist
Select watchlists to add or remove NXTC